107 related articles for article (PubMed ID: 22699805)
1. Effects of beta-blocker use on volume status in hemodialysis patients.
Bi SH; Linke L; Wu J; Cheng LT; Wang T; Ahmad S
Blood Purif; 2012; 33(4):311-6. PubMed ID: 22699805
[TBL] [Abstract][Full Text] [Related]
2. Residual renal function and volume control in peritoneal dialysis patients.
Cheng LT; Chen W; Tang W; Wang T
Nephron Clin Pract; 2006; 104(1):c47-54. PubMed ID: 16741370
[TBL] [Abstract][Full Text] [Related]
3. Effects of relative blood volume-controlled hemodialysis on blood pressure and volume status in hypertensive patients.
Dasselaar JJ; Huisman RM; de Jong PE; Burgerhof JG; Franssen CF
ASAIO J; 2007; 53(3):357-64. PubMed ID: 17515729
[TBL] [Abstract][Full Text] [Related]
4. [Control of arterial hypertension by means of a regimen of hemodialysis on alternate days (HDAA or EODD: "Every Other Day Dialysis") versus 2 conventional regiments of 4 and 5 hours per session 3 times a week with 72 hours without sessions during the weekends].
Lozano A; Benavides B; Quirós P; Jiménez-Moreno J; Figueroa E; Fernández-Marchena D; García-Pérez MA; Fernández-Ruiz E
Nefrologia; 2006; 26(6):695-702. PubMed ID: 17227247
[TBL] [Abstract][Full Text] [Related]
5. Effectiveness comparison of cardio-selective to non-selective β-blockers and their association with mortality and morbidity in end-stage renal disease: a retrospective cohort study.
Shireman TI; Mahnken JD; Phadnis MA; Ellerbeck EF
BMC Cardiovasc Disord; 2016 Mar; 16():60. PubMed ID: 27012911
[TBL] [Abstract][Full Text] [Related]
6. Antihypertensive effects of long-acting calcium channel blockers on hemodialysis days--a randomized crossover trial between benidipine and nifedipine CR.
Kojima M; Taniguchi M; Sato K; Ueda R; Dohi Y
Nephron Clin Pract; 2004; 97(2):c49-53. PubMed ID: 15218330
[TBL] [Abstract][Full Text] [Related]
7. Daily dialysis reduces pulse wave velocity in chronic hemodialysis patients.
Di Micco L; Torraca S; Sirico ML; Tartaglia D; Di Iorio B
Hypertens Res; 2012 May; 35(5):518-22. PubMed ID: 22278627
[TBL] [Abstract][Full Text] [Related]
8. Intensive Hemodialysis, Blood Pressure, and Antihypertensive Medication Use.
Bakris GL; Burkart JM; Weinhandl ED; McCullough PA; Kraus MA
Am J Kidney Dis; 2016 Nov; 68(5S1):S15-S23. PubMed ID: 27772639
[TBL] [Abstract][Full Text] [Related]
9. Prolonged protective effect of short daily hemodialysis against dialysis-induced hypotension.
Okada K; Abe M; Hagi C; Maruyama T; Maruyama N; Ito K; Higuchi T; Matsumoto K; Takahashi S
Kidney Blood Press Res; 2005; 28(2):68-76. PubMed ID: 15677874
[TBL] [Abstract][Full Text] [Related]
10. Why is there significant overlap in volume status between hypertensive and normotensive patients on dialysis?
Cheng LT; Tian JP; Tang LJ; Chen HM; Gu Y; Du FH; Wang T
Am J Nephrol; 2008; 28(3):508-16. PubMed ID: 18204249
[TBL] [Abstract][Full Text] [Related]
11. [Hypertension in hemodialysis patients in Andalucia].
García Cortés MJ; Ceballos M;
Nefrologia; 2004; 24(2):149-57. PubMed ID: 15219090
[TBL] [Abstract][Full Text] [Related]
12. Can predialysis hypertension prevent intradialytic hypotension in hemodialysis patients?
Takeda A; Toda T; Fujii T; Sasaki S; Matsui N
Nephron Clin Pract; 2006; 103(4):c137-43. PubMed ID: 16636581
[TBL] [Abstract][Full Text] [Related]
13. Beta-blockers and cardiovascular outcomes in dialysis patients: a cohort study in Ontario, Canada.
Kitchlu A; Clemens K; Gomes T; Hackam DG; Juurlink DN; Mamdani M; Manno M; Oliver MJ; Quinn RR; Suri RS; Wald R; Yan AT; Garg AX
Nephrol Dial Transplant; 2012 Apr; 27(4):1591-8. PubMed ID: 21873621
[TBL] [Abstract][Full Text] [Related]
14. Nebivolol: a third-generation beta-blocker for hypertension.
Cheng JW
Clin Ther; 2009 Mar; 31(3):447-62. PubMed ID: 19393838
[TBL] [Abstract][Full Text] [Related]
15. Control of hypertension is better during hemodialysis than during continuous ambulatory peritoneal dialysis in ESRD patients.
Velasquez MT; Lew SQ; von Albertini B; Mishkin GJ; Bosch JP
Clin Nephrol; 1997 Dec; 48(6):341-5. PubMed ID: 9438091
[TBL] [Abstract][Full Text] [Related]
16. Impact of volume status on blood pressure and left ventricle structure in patients undergoing chronic hemodialysis.
Koc Y; Unsal A; Kayabasi H; Oztekin E; Sakaci T; Ahbap E; Yilmaz M; Akgun AO
Ren Fail; 2011; 33(4):377-81. PubMed ID: 21529265
[TBL] [Abstract][Full Text] [Related]
17. [Arterial hypertension in chronic kidney failure: a volume-dependent pathology or a disease due to malnutrition?].
Iannetti E; Carpinteri G; Trovato GM
G Ital Cardiol; 1999 Mar; 29(3):284-90. PubMed ID: 10231674
[TBL] [Abstract][Full Text] [Related]
18. Importance of volume factors in dialysis related hypertension.
Lins RL; Elseviers M; Rogiers P; Van Hoeyweghen RJ; De Raedt H; Zachee P; Daelemans RA
Clin Nephrol; 1997 Jul; 48(1):29-33. PubMed ID: 9247775
[TBL] [Abstract][Full Text] [Related]
19. Drug therapy for hypertension in hemodialysis patients.
Hörl MP; Tepel M
Minerva Med; 2005 Aug; 96(4):277-85. PubMed ID: 16179894
[TBL] [Abstract][Full Text] [Related]
20. The therapeutic importance of home blood pressure assessment and combination antihypertensive therapy for achieving target blood pressure control: Ibaraki hypertension assessment trial.
Sato A; Watanabe S; Okubo S; Toi T; Doi T; Nakano H; Tada J; Aonuma K;
Hypertens Res; 2010 Dec; 33(12):1264-71. PubMed ID: 20927115
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
